CCL3 and colorectal carcinoma: Additionally, in vitro exposure of CCL3 to SMA-positive cells binding to CCR5 resulted in enhanced cell migration and an increase in EGF expression, an essential growth factor for CRC cells, and was inhibited by maraviroc.